Advertisement
Advertisement

ORMP

ORMP logo

Oramed Pharmaceuticals Inc.

5.14
USD
Sponsored
+0.84
+19.53%
Jun 25, 13:43 UTC -4
Open

ORMP Earnings Reports

Positive Surprise Ratio

ORMP beat 12 of 16 last estimates.

75%

Next Report

Date of Next Report
Jul 15, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
$0.19
Implied change from Q4 25 (Revenue/ EPS)
--
/
-20.83%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-83.04%

Oramed Pharmaceuticals Inc. earnings per share and revenue

On Mar 26, 2026, ORMP reported earnings of 0.24 USD per share (EPS) for Q4 25, Inline the estimate of 0.00 USD, resulting in a 0.00% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -5.14% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of 0.19 USD, with revenue projected to reach -- USD, implying an decrease of -20.83% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Canopy Growth Corporation Common Shares
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.09
Actual
-$0.40
Surprise
-309.74%
logo
High Tide Inc. Common Shares
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.02
Actual
$0.01
Surprise
+135.97%
logo
Aurora Cannabis Inc. Common Shares
Report Date
Jun 11, 2026 For Q4 26
Estimate
-$0.08
Actual
$0.11
Surprise
+228.06%
FAQ
For Q4 2025, Oramed Pharmaceuticals Inc. reported EPS of $0.24, missing estimates by 0%, and revenue of $0.00, 0% as expectations.
The stock price moved down -5.14%, changed from $3.50 before the earnings release to $3.32 the day after.
The next earning report is scheduled for Jul 15, 2026.
Based on -- analysts, Oramed Pharmaceuticals Inc. is expected to report EPS of $0.19 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement